会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Device and method for detection and treatment of syncope
    • 用于检测和治疗晕厥的装置和方法
    • US6078834A
    • 2000-06-20
    • US257566
    • 1999-02-25
    • Keith G. LurieDavid BendittStanislao F. ObinoPaul J. Buscemi
    • Keith G. LurieDavid BendittStanislao F. ObinoPaul J. Buscemi
    • A61M5/172A61N1/365A61M5/142
    • A61M5/1723A61N1/365A61N1/36571A61N1/36592
    • The invention disclosed herein relates to an implantable medical device for detection and treatment of syncope comprising an algorithm for determining the presence of syncope based on physiological activity associated with the onset of a syncopal episode, and a means for infusion a drug. Drug infusion therapy may be used along or in combination with pacing. The physiological activities detected and used by the device are selected from the group including changes in heart rate, heart rate variability, QT interval, PR interval, pressure, blood flow, vagal nerve activity, temperature, pH, and AV conduction times, respiration rate, position, motion, and combinations thereof. Drugs which may be used with the invention include pharmaceutical compositions which are capable of both endocardial administration and treatment of syncope, such as compositions comprising beta-blockers.
    • 本文公开的本发明涉及用于检测和治疗晕厥的可植入医疗装置,其包括用于基于与晕厥发作相关的生理活动来确定晕厥的存在的算法,以及用于输注药物的装置。 药物输注治疗可以与起搏一起使用或与起搏组合使用。 该装置检测和使用的生理活动选自心率,心率变异性,QT间期,PR间期,压力,血流,迷走神经活动,温度,pH和AV传导时间的变化,呼吸频率 ,位置,运动及其组合。 可用于本发明的药物包括能够同时进行心内膜施用和治疗晕厥的药物组合物,例如包含β-受体阻滞剂的组合物。